This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2491) mHealth in a Clinical Setting (624) Dementia and Cognitive Decline (502) Diagnostic Tools in Mental Health (248)

Published on in Vol 3, No 3 (2019): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13417, first published .
Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease

Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease

Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease

Authors of this article:

Ingrid S van Maurik1, 2 Author Orcid Image ;   Leonie NC Visser1, 3 Author Orcid Image ;   Ruth E Pel-Littel4 Author Orcid Image ;   Marieke M van Buchem1 Author Orcid Image ;   Marissa D Zwan1 Author Orcid Image ;   Marleen Kunneman3, 5 Author Orcid Image ;   Wiesje Pelkmans1 Author Orcid Image ;   Femke H Bouwman1 Author Orcid Image ;   Mirella Minkman4, 6 Author Orcid Image ;   Niki Schoonenboom7 Author Orcid Image ;   Philip Scheltens1 Author Orcid Image ;   Ellen MA Smets3 Author Orcid Image ;   Wiesje M van der Flier1, 2 Author Orcid Image
Article Authors Cited by (38) Tweetations (2) Metrics

Journals

  1. van Maurik I, Vos S, Bos I, Bouwman F, Teunissen C, Scheltens P, Barkhof F, Frolich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Frisoni G, Spiru L, Freund-Levi Y, Wallin A, Hampel H, Soininen H, Tsolaki M, Verhey F, Kłoszewska I, Mecocci P, Vellas B, Lovestone S, Galluzzi S, Herukka S, Santana I, Baldeiras I, de Mendonça A, Silva D, Chetelat G, Egret S, Palmqvist S, Hansson O, Visser P, Berkhof J, van der Flier W. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. The Lancet Neurology 2019;18(11):1034 View
  2. Visser L, Kunneman M, Murugesu L, van Maurik I, Zwan M, Bouwman F, Schuur J, Wind H, Blaauw M, Kragt J, Roks G, Boelaarts L, Schipper A, Schooneboom N, Scheltens P, van der Flier W, Smets E. Clinician‐patient communication during the diagnostic workup: The ABIDE project. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2019;11(1):520 View
  3. Visser L, van Maurik I, Bouwman F, Staekenborg S, Vreeswijk R, Hempenius L, de Beer M, Roks G, Boelaarts L, Kleijer M, van der Flier W, Smets E, Ginsberg S. Clinicians’ communication with patients receiving a MCI diagnosis: The ABIDE project. PLOS ONE 2020;15(1):e0227282 View
  4. Zahid M, Gallant N, Hadjistavropoulos T, Stroulia E. Behavioral Pain Assessment Implementation in Long-Term Care Using a Tablet App: Case Series and Quasi-Experimental Design. JMIR mHealth and uHealth 2020;8(4):e17108 View
  5. Harst L, Wollschlaeger B. Smart Homes – Intelligente Systeme im häuslichen Umfeld. ergopraxis 2020;13(11/12):47 View
  6. Harst L, Wollschlaeger B. Smart Homes – Intelligente Systeme im häuslichen Umfeld. physiopraxis 2020;18(11/12):59 View
  7. Leuzy A, Ashton N, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni G, Garibotto V, Hansson O. 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework. European Journal of Nuclear Medicine and Molecular Imaging 2021;48(7):2121 View
  8. Rostamzadeh A, Schwegler C, Gil-Navarro S, Rosende-Roca M, Romotzky V, Ortega G, Canabate P, Moreno M, Schmitz-Luhn B, Boada M, Jessen F, Woopen C. Biomarker-Based Risk Prediction of Alzheimer’s Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects. Journal of Alzheimer's Disease 2021;80(2):601 View
  9. Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen C, Cummings J, van der Flier W. Alzheimer's disease. The Lancet 2021;397(10284):1577 View
  10. Cullen N, Leuzy A, Janelidze S, Palmqvist S, Svenningsson A, Stomrud E, Dage J, Mattsson-Carlgren N, Hansson O. Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nature Communications 2021;12(1) View
  11. Linden I, Wolfs C, Perry M, Metsemakers J, van der Weijden T, de Vugt M, Verhey F, Handels R, Olde Rikkert M, Dirksen C, Ponds R. Implementation of a diagnostic decision aid for people with memory complaints and their general practitioners: a protocol of a before and after pilot trial. BMJ Open 2021;11(6):e049322 View
  12. Harst L, Wollschlaeger B, Birnstein J, Fuchs T, Timpel P. Evaluation is Key: Providing Appropriate Evaluation Measures for Participatory and User-Centred Design Processes of Healthcare IT. International Journal of Integrated Care 2021;21(2) View
  13. Hampel H, Au R, Mattke S, van der Flier W, Aisen P, Apostolova L, Chen C, Cho M, De Santi S, Gao P, Iwata A, Kurzman R, Saykin A, Teipel S, Vellas B, Vergallo A, Wang H, Cummings J. Designing the next-generation clinical care pathway for Alzheimer’s disease. Nature Aging 2022;2(8):692 View
  14. Kimmel H, Levine D, Whitney R, Forman J, Plassman B, Fagerlin A, Welsh-Bohmer K, Reale B, Galecki A, Blair E, Langa K, Giordani B, Kollman C, Wang J, Zahuranec D, Ayton D. A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks. Journal of Alzheimer's Disease 2022;85(3):1175 View
  15. van Gils A, Visser L, Hendriksen H, Georges J, van der Flier W, Rhodius‐Meester H. Development and design of a diagnostic report to support communication in dementia: Co‐creation with patients and care partners. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2022;14(1) View
  16. Leuzy A, Mattsson‐Carlgren N, Palmqvist S, Janelidze S, Dage J, Hansson O. Blood‐based biomarkers for Alzheimer's disease. EMBO Molecular Medicine 2022;14(1) View
  17. Bellio M, Furniss D, Oxtoby N, Garbarino S, Firth N, Ribbens A, Alexander D, Blandford A. Opportunities and Barriers for Adoption of a Decision-Support Tool for Alzheimer’s Disease. ACM Transactions on Computing for Healthcare 2021;2(4):1 View
  18. van Gils A, Visser L, Hendriksen H, Georges J, Muller M, Bouwman F, van der Flier W, Rhodius-Meester H. Assessing the Views of Professionals, Patients, and Care Partners Concerning the Use of Computer Tools in Memory Clinics: International Survey Study. JMIR Formative Research 2021;5(12):e31053 View
  19. van Lonkhuizen P, Vegt N, Meijer E, van Duijn E, de Bot S, Klempíř J, Frank W, Landwehrmeyer G, Mühlbäck A, Hoblyn J, Squitieri F, Foley P, Chavannes N, Heemskerk A. Study Protocol for the Development of a European eHealth Platform to Improve Quality of Life in Individuals With Huntington's Disease and Their Partners (HD-eHelp Study): A User-Centered Design Approach. Frontiers in Neurology 2021;12 View
  20. Visser L, Minguillon C, Sánchez-Benavides G, Abramowicz M, Altomare D, Fauria K, Frisoni G, Georges J, Ribaldi F, Scheltens P, van der Schaar J, Zwan M, van der Flier W, Molinuevo J. Dementia risk communication. A user manual for Brain Health Services—part 3 of 6. Alzheimer's Research & Therapy 2021;13(1) View
  21. Fruijtier A, van der Schaar J, van Maurik I, Zwan M, Scheltens P, Bouwman F, Pijnenburg Y, van Berckel B, Ebenau J, van der Flier W, Smets E, Visser L. Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial. Alzheimer's & Dementia 2023;19(1):285 View
  22. Visser L, Fruijtier A, Kunneman M, Bouwman F, Schoonenboom N, Staekenborg S, Wind H, Hempenius L, de Beer M, Roks G, Boelaarts L, Kleijer M, Smets E, van der Flier W. Motivations of patients and their care partners for visiting a memory clinic. A qualitative study. Patient Education and Counseling 2023;111:107693 View
  23. Thieme A, Hanratty M, Lyons M, Palacios J, Marques R, Morrison C, Doherty G. Designing Human-centered AI for Mental Health: Developing Clinically Relevant Applications for Online CBT Treatment. ACM Transactions on Computer-Human Interaction 2023;30(2):1 View
  24. Alhasani R, George N, Radman D, Auger C, Ahmed S. Methodologies for Evaluating the Usability of Rehabilitation Technologies Aimed at Supporting Shared Decision-Making: Scoping Review. JMIR Rehabilitation and Assistive Technologies 2023;10:e41359 View
  25. van der Flier W, de Vugt M, Smets E, Blom M, Teunissen C. Towards a future where Alzheimer’s disease pathology is stopped before the onset of dementia. Nature Aging 2023;3(5):494 View
  26. Rahman‐Filipiak A, Bolton C, Grill J, Rostamzadeh A, Chin N, Heidebrink J, Getz S, Fowler N, Rosen A, Lingler J, Wijsman E, Clark L. Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials. Alzheimer's & Dementia 2023;19(9):4270 View
  27. Hendriksen H, van Gils A, van Harten A, Hartmann T, Mangialasche F, Kamondi A, Kivipelto M, Rhodius-Meester H, Smets E, van der Flier W, Visser L. Communication about diagnosis, prognosis, and prevention in the memory clinic: perspectives of European memory clinic professionals. Alzheimer's Research & Therapy 2023;15(1) View
  28. Hazan J, Liu K, Fox N, Howard R. Online clinical tools to support the use of new plasma biomarker diagnostic technology in the assessment of Alzheimer’s disease: a narrative review. Brain Communications 2023;5(6) View
  29. Pozzi F, Remoli G, Tremolizzo L, Appollonio I, Ferrarese C, Cuffaro L. Brain Health and Cognition in Older Adults: Roadmap and Milestones towards the Implementation of Preventive Strategies. Brain Sciences 2024;14(1):55 View
  30. Postema M, Dubbelman M, Claesen J, Ritchie C, Verrijp M, Visser L, Visser P, Zwan M, van der Flier W, Sikkes S. Facilitating clinical use of the Amsterdam Instrumental Activities of Daily Living Questionnaire: Normative data and a diagnostic cutoff value. Journal of the International Neuropsychological Society 2024;30(6):615 View
  31. Aspö M, Sundell M, Protsiv M, Wiggenraad F, Rydén M, Mangialasche F, Kivipelto M, Visser L. The expectations and experiences of patients regarding the diagnostic workup at a specialized memory clinic: An interview study. Health Expectations 2024;27(2) View
  32. Daube D, Reifegerste D. Digitale Informationsmaterialen über Demenz – Eine explorative inhaltsanalytische Betrachtung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2024;67(8):947 View
  33. Hendriksen H, de Rijke T, Fruijtier A, van de Giessen E, van Harten A, van Leeuwenstijn‐Koopman M, van der Schaar J, Trieu C, Visser D, Smets E, Visser L, van der Flier W. Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time. Alzheimer's & Dementia 2024;20(9):6556 View
  34. Groos S, de Wildt K, van de Loo B, Linn A, Medlock S, Shaw K, Herman E, Seppala L, Ploegmakers K, van Schoor N, van Weert J, van der Velde N, Baysal M. Development of the ADFICE_IT clinical decision support system to assist deprescribing of fall-risk increasing drugs: A user-centered design approach. PLOS ONE 2024;19(9):e0297703 View
  35. Perry J, Radenbach K, Geschke K, Rostamzadeh A. Counseling and disclosure practices in predictive Alzheimer's disease diagnostics: A scoping review. Alzheimer's & Dementia 2024 View
  36. Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A, Golabi B, Aletaha R, Motlagh Asghari K, Hamidi S, Mousavi S, Jamalkhani S, Karamzad N, Shamekh A, Mohammadinasab R, Sullman M, Şahin F, Kolahi A. Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. Frontiers in Medicine 2024;11 View